|
Parkinson's disease/Parkinsonism
Citations 71-80 of 519 total displayed.
|
Past content
(since Jan 2000):
|
- VIDEO NEUROIMAGES
Kick and rush: Paradoxical kinesia in Parkinson disease
- Friedrich Asmus, Heiko Huber, Thomas Gasser, and Ludger Schöls
Neurology 2008; 71: 695.
[Full text]
[PDF]
- EDITORIALS
Agonist or levodopa for Parkinson disease?: Ultimately, it doesn't matter; neither is good enough
- William J. Weiner and Stephen G. Reich
Neurology 2008; 71: 470-471.
[Full text]
[PDF]
- ARTICLES
Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD
- R. Katzenschlager, J. Head, A. Schrag, Y. Ben-Shlomo, A. Evans, A. J. Lees On behalf of the Parkinson's Disease Research Group of the United Kingdom
Neurology 2008; 71: 474-480.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Fatigue in levodopa-naïve subjects with Parkinson disease
- G. Schifitto, J. H. Friedman, D. Oakes, L. Shulman, C. L. Comella, K. Marek, S. Fahn, and The Parkinson Study Group ELLDOPA Investigators
Neurology 2008; 71: 481-485.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Celiac antibodies in the diagnostic workup of white matter lesions
- F. Paul, C. F. Pfueller, J. T. Wuerfel, K. Egerer, B. Tanczos, D. C. Baumgart, and F. Zipp
Neurology 2008; 71: 223-225.
[Full text]
[PDF]
- EDITORIALS
Fine-tuning gait in Parkinson disease
- Michele Tagliati
Neurology 2008; 71: 76-77.
[Full text]
[PDF]
- ARTICLES
STN-DBS frequency effects on freezing of gait in advanced Parkinson disease
- C. Moreau, L. Defebvre, A. Destée, S. Bleuse, F. Clement, J. L. Blatt, P. Krystkowiak, and D. Devos
Neurology 2008; 71: 80-84.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Association, expression, pathobiology: Is too much tau in PD a blueprint for genetic association?
- Andrew Singleton and Huw Morris
Neurology 2008; 71: 11-12.
[Full text]
[PDF]
- ARTICLES
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: The GenePD Study
- J. E. Tobin, J. C. Latourelle, M. F. Lew, C. Klein, O. Suchowersky, H. A. Shill, L. I. Golbe, M. H. Mark, J. H. Growdon, G. F. Wooten, B. A. Racette, J. S. Perlmutter, R. Watts, M. Guttman, K. B. Baker, S. Goldwurm, G. Pezzoli, C. Singer, M. H. Saint-Hilaire, A. E. Hendricks, S. Williamson, M. W. Nagle, J. B. Wilk, T. Massood, J. M. Laramie, A. L. DeStefano, I. Litvan, G. Nicholson, A. Corbett, S. Isaacson, D. J. Burn, P. F. Chinnery, P. P. Pramstaller, S. Sherman, J. Al-hinti, E. Drasby, M. Nance, A. T. Moller, K. Ostergaard, R. Roxburgh, B. Snow, J. T. Slevin, F. Cambi, J. F. Gusella, and R. H. Myers
Neurology 2008; 71: 28-34.
[Abstract]
[Full text]
[PDF]
- ARTICLES
A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease
- M. Stacy, D. Silver, T. Mendis, J. Sutton, A. Mori, P. Chaikin, and N. M. Sussman
Neurology 2008; 70: 2233-2240.
[Abstract]
[Full text]
[PDF]
|
|
